Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pregabalin. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced nitro-reduction pathway for S-Pregabalin offers safer scalable manufacturing and significant cost reduction in API production without high-pressure carbon monoxide.
Novel catalytic route for pregabalin intermediates avoids toxic reagents. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical partners.
Patent CN117448309A reveals biocatalytic synthesis for high-purity pregabalin intermediates. Achieve significant cost reduction and supply chain reliability.
Patent CN102382785B reveals a novel Morganella morganii strain for high-purity Pregabalin intermediate production, offering significant cost and supply chain advantages.
Novel 3-step route for Pregabalin avoids resolution waste. High ee value up to 99.6%. Cost-effective manufacturing for pharma intermediates.
Patent CN102465157B details enzymatic synthesis of pregabalin intermediate offering high purity and scalable supply chain solutions for global pharmaceutical manufacturers.
Patent CN114164198B enables enzymatic synthesis of chiral intermediates. This route offers substantial cost reduction and supply chain reliability for global pharmaceutical manufacturing partners.
Patent CN1642899A details a novel aqueous method for producing gamma-amino acids like gabapentin and pregabalin, offering significant cost and safety advantages for pharmaceutical manufacturers.
Novel solvent-free route for 4-isobutyl pyrrolidone ensures high purity and cost efficiency for pregabalin supply chains.
Patent CN116554062A reveals solvent-free synthesis for high-purity Pregabalin Impurity II. Enhances supply chain reliability and reduces manufacturing costs significantly.
Patent CN105367434A details isobutyraldehyde route for pregabalin. Ensures high purity and supply chain stability for global pharmaceutical manufacturing needs.
Novel patent CN105061234A offers high-purity pregabalin route. Reduces costs and improves supply chain reliability for pharmaceutical intermediate manufacturing globally.
Patent CN102382785A details a novel biocatalytic route for high-purity pregabalin intermediates. Discover cost-effective manufacturing and supply chain advantages.
Novel lipase mutant enables high-purity pregabalin intermediate production with improved activity and supply chain reliability for pharmaceutical manufacturing.
Patent CN105985292B enables mild asymmetric catalysis. Delivers high-purity pharmaceutical intermediates with substantial cost reduction and supply chain reliability.
Patent CN103626668A offers high-efficiency resolution for S-pregabalin. Enhances supply chain reliability and reduces manufacturing costs significantly.
Patent CN114686465A reveals a hydrolase method for (R)-3-(carbamoylmethyl)-5-methylhexanoic acid, offering green, high-yield production for reliable supply chains.
Novel ammonium sulfate process for 3-isobutylglutaric acid. Enhances purity and supply chain reliability for pregabalin intermediate production globally.
Patent CN113804805B details a green, solvent-free method for synthesizing Pregabalin Impurity II. This breakthrough ensures reliable quality control standards and reduces manufacturing costs for pharmaceutical intermediates.
Novel green synthesis of ethyl 2-acetyl-3-nitromethylene-5-methyl-hexanoate using recyclable DES solvent, offering high yield and cost efficiency.